Small-molecule HIV-1 entry inhibitors targeting gp120 and gp41: a patent review (2010-2015)
{{output}}
It is essential to discover and develop small-molecule HIV-1 entry inhibitors with suitable pharmaceutical properties. Areas covered: We review the development of small-molecule HIV-1 entry inhibitors as evidenced in patents, patent applications, and related r... ...